Rwanda vs United Kingdom: Access to anti-retroviral drugs, male (%)
Rwanda
95.0%
in 2024
United Kingdom
93.0%
in 2023
Rwanda rank
4th
United Kingdom rank
7th
Access to anti-retroviral drugs, male (%) over time
- Rwanda
- United Kingdom
How they compare
Rwanda currently reports 95.0% against 93.0% in United Kingdom, a difference of 2.0%.
The two have swapped places 1 time across 8 shared years of data; in 2016 it was United Kingdom ahead.
Rwanda ranks 4th and United Kingdom ranks 7th of 141 countries.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.0% | 92.0% | 16.0% | United Kingdom |
| 2020s | 88.8% | 93.2% | 4.5% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Rwanda or United Kingdom?
- Rwanda, at 95.0% against 93.0% in United Kingdom as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Rwanda and United Kingdom?
- 2.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do Rwanda and United Kingdom rank globally for access to anti-retroviral drugs, male?
- Rwanda ranks 4th and United Kingdom ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.